Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus

被引:23
作者
González, C
Garcia-Berrocal, B
Herráez, O
Navajo, JA
González-Buitrago, JM
机构
[1] Hosp Univ Salamanca, Serv Bioquim, Lab Autoinmunidad, Salamanca, Spain
[2] Univ Salamanca, Dept Bioquim & Biol Mol, E-37008 Salamanca, Spain
关键词
ANA-positive patients; anti-chromatin antibodies; anti-dsDNA antibodies; anti-nucleosome antibodies; systemic lupus erythematosus (SLE);
D O I
10.1515/CCLM.2004.049
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Antinucleosome (antichromatin) antibodies play a key role in the pathogenesis of systemic lupus erythematosus (SLE). The objective of the present study was to determine the clinical significance of antinucleosome (antichromatin) antibodies, antidsDNA antibodies and antihistone antibodies in patients with SLE in relation to patients with positive nuclear antibodies and healthy controls. We measured antinucleosome (antichromatin) antibodies, antidsDNA antibodies and antihistone antibodies in 70 patients with SLE, 35 antinuclear antibody (ANA)positive subjects without autoimmune disease and 35 blood donors. All antibodies were determined by enzyme linked immunosorbent assay (ELISA). We obtained the receiver operating caracteristic (ROC) curve and the area under the curve (AUC) for each autoantibody. Likewise, we obtained the sensitivity, specificity and positive and negative likelihood ratios for each autoantibody. The highest AUC was obtained for antinucleosome (0.898) and the lowest AUC for a kit for antidsDNA (0.725). Stratification of the control group (ANApositive subjects without autoimmune disease and blood donors) produced significant changes in the AUCs; all AUCs decreased when ANApositive patients without autoimmune disease were considered as controls and all AUCs increased when blood donors were considered as controls. These effects were less marked in antidsDNA antibodies. We observed discrepancies between kits (antinucleosome and antichromatin and two for antidsDNA). The highest sensitivity for SLE was obtained for antinucleosome antibodies (86%) and the highest specificity was obtained for antidsDNA antibodies (90%). In conclusion, antinucleosome and antichromatin kits show different degrees of clinical accuracy due to the cutoff selected by the manufacturer. Once the kits with the best performance and the optimal cutoffs have been selected, antinucleosome antibodies and antidsDNA antibodies provide similar information in established SLE.
引用
收藏
页码:266 / 272
页数:7
相关论文
共 29 条
[1]   Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus - Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity [J].
Amoura, Z ;
Piette, JC ;
Chabre, H ;
Cacoub, P ;
Papo, T ;
Wechsler, B ;
Bach, JF ;
Koutouzov, S .
ARTHRITIS AND RHEUMATISM, 1997, 40 (12) :2217-2225
[2]  
Amoura Z, 2000, ARTHRITIS RHEUM-US, V43, P76, DOI 10.1002/1529-0131(200001)43:1<76::AID-ANR10>3.0.CO
[3]  
2-I
[4]  
Andreassen K, 1999, EUR J IMMUNOL, V29, P2715, DOI 10.1002/(SICI)1521-4141(199909)29:09<2715::AID-IMMU2715>3.0.CO
[5]  
2-#
[6]   T cell Autoimmunity to histones and nucleosomes is a latent property of the normal immune system [J].
Andreassen, K ;
Bendiksen, S ;
Kjeldsen, E ;
Van Ghelue, M ;
Arnesen, E ;
Rekvig, OP .
ARTHRITIS AND RHEUMATISM, 2002, 46 (05) :1270-1281
[7]  
Andreassen K, 1999, ARTHRITIS RHEUM, V42, P2449, DOI 10.1002/1529-0131(199911)42:11<2449::AID-ANR24>3.0.CO
[8]  
2-P
[9]   Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus [J].
Arbuckle, MR ;
James, JA ;
Kohlhase, KF ;
Rubertone, MV ;
Dennis, GJ ;
Harley, JB .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (1-2) :211-219
[10]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640